Generated August 10, 2026 at 8:30 PM ET
· Covers August 10 trading day
· 6 of 347 ready 8-Ks selected
· AI-assisted overview
The day's filings featured multiple major corporate actions. HWH International completed a $10 million PIPE, giving Smart Dynamics 67.3% control and expanding its board. Amneal Pharmaceuticals closed its $375 million cash-plus-stock acquisition of Kashiv BioSciences, with milestone and royalty provisions. Bowman Consulting agreed to be acquired by Bernhard Capital Partners for $43.00 per share in cash, subject to a go-shop period. Clene reported biomarker analyses showing survival benefits for its ALS treatment CNM-Au8, while Northann Corp. disclosed a trading halt, auditor resignation, and non-reliable financials. Riot Platforms posted Q2 revenue up 14% to $174 million and announced a $9.1 billion AI data center lease.
HWH
HWH International Inc.
M&A
negative
materiality 1.00
August 10, 2026, 4:45 PM ET
HWH completes $10M PIPE; Smart Dynamics takes 67.3% control, new directors appointed
- Closed Aug 10, 2026: issued 20M shares + 160M warrants at $0.63 (expire 2030) for $10M.
- Smart Dynamics now owns 67.3% of outstanding stock (29.7M shares); Alset falls to 18.6%, Chan to 27%.
- Board expanded 5 to 8; Liu Chang, Liu Ming Xing, Liu Ming Hui appointed as new directors.
AMRX
Amneal Pharmaceuticals, Inc.
M&A
positive
materiality 1.00
August 10, 2026, 4:05 PM ET
Amneal closes $375M cash-plus-stock acquisition of Kashiv BioSciences
- Closed Aug 10, 2026; paid $375M cash plus 28,942,098 Class A shares (fractional adjustment).
- Sellers eligible for up to $350M in U.S. regulatory milestone payments for six Kashiv candidates.
- 12-year royalty tail: 25% of gross profits above hurdle amounts for certain products.
BWMN
Bowman Consulting Group Ltd.
M&A
positive
materiality 1.00
August 10, 2026, 9:21 AM ET
Bowman Consulting to be acquired by Bernhard Capital Partners for $43.00/share in cash
- Merger agreement with Prive Parent (BCP affiliate) values BWMN at $43.00 per share in cash.
- Board unanimously recommends; go-shop period runs until Sept 13, 2026.
- Termination fees: Company pays $26.86M (or $13.43M for Excluded Party); Parent pays $46.05M.
regulatory
positive
materiality 0.85
August 10, 2026, 8:07 AM ET
Clene reports biomarker analyses showing CNM-Au8 survival benefit in NfL responders for ALS NDA
- CNM-Au8 30 mg cut death risk 74% at 12 months vs controls in HEALEY (p=0.0124); 38% lower risk over full follow-up (HR 0.621, p=0.037).
- Causal analysis: 41% lower death risk in predicted NfL responders (HR 0.593, p=0.026); no benefit in non-responders.
- RESCUE-ALS: NfL responders had 76% lower adjusted death risk vs non-responders (HR 0.24, p=0.008); median survival 43.5 vs 19.9 months.
other material
negative
materiality 1.00
August 10, 2026, 5:25 PM ET
Northann trading halted, auditor resigns, financials non-reliable, chairman replaced
- NYSE American halted NCL trading June 25, 2026 over 10-K filed without auditor approval; halt remains.
- Auditor LAO Professionals resigned June 8, 2026; disclaimed audit report and said 10-K filed without its consent.
- Company advises investors not to rely on FY2024/2025 financials; new audit to be performed by replacement firm.
RIOT
Riot Platforms, Inc.
earnings
positive
materiality 0.90
August 10, 2026, 4:22 PM ET
Riot posts Q2 revenue up 14% to $174M; inks $9.1B AI data center lease
- Q2 revenue $174.2M (+14% YoY); net loss $(237)M, diluted EPS $(0.68); adjusted EBITDA $(70)M.
- Signed 20-yr, 191 MW lease with frontier AI lab at Rockdale, $9.1B initial revenue, up to $16.1B with extensions.
- Delivered initial 25 MW to AMD on schedule; 25 MW expansion under construction, full 50 MW by May 2027.